Clinical evaluation of weekly 1-hour infusion of paclitaxel in patients with hormone-refractory prostate cancer

被引：0
|
作者：
Hussain, M
机构：
[1] Wayne State Univ, Detroit, MI USA
[2] Karmanos Canc Inst, Detroit, MI USA
来源：
SEMINARS IN ONCOLOGY | 1999年 / 26卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：138 / 138
页数：1
相关论文
共 50 条
  • [21] Weekly administration of docetaxel in patients with hormone-refractory prostate cancer: a pilot study on Japanese patients
    Kojima, T
    Shimazui, T
    Onozawa, M
    Tsukamoto, S
    Hinotsu, S
    Miyanaga, N
    Hattori, K
    Kawai, K
    Akaza, H
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2004, 34 (03) : 137 - 141
  • [22] Chemotherapy for patients with hormone-refractory prostate cancer
    Joly, F
    Tannock, IF
    ANNALS OF ONCOLOGY, 2004, 15 (11) : 1582 - 1584
  • [23] Weekly docetaxel for advanced hormone-refractory prostate cancer-HRPC
    Pepe, A.
    Usset, A.
    Calabria, C.
    Savio, G.
    Palmisano, V
    Leonardi, V
    Laudani, A.
    Arcuri, C.
    Giresi, A.
    Agostara, B.
    ANNALS OF ONCOLOGY, 2006, 17 : XI82 - XI82
  • [24] Monthly paclitaxel and carboplatin with oral estramustine phosphate in patients with hormone-refractory prostate cancer
    Segawa T.
    Kamoto T.
    Kinoshita H.
    Kunishima Y.
    Yoshimura K.
    Ito A.
    Takahashi T.
    Higashi S.
    Nakamura E.
    Nishiyama H.
    Ito N.
    Yamamoto S.
    Habuchi T.
    Ogawa O.
    International Journal of Clinical Oncology, 2005, 10 (5) : 333 - 337
  • [25] Weekly docetaxel for advanced hormone-refractory prostate cancer-hrpc
    Pepe, A.
    Usset, A.
    Calabria, C.
    Savio, G.
    Palmisano, V
    Leonardi, V
    Laudani, A.
    Arcuri, C.
    Agostara, B.
    ANNALS OF ONCOLOGY, 2007, 18 : 187 - 187
  • [26] Hormone-Refractory prostate cancer
    Rini B.I.
    Small E.J.
    Current Treatment Options in Oncology, 2002, 3 (5) : 437 - 446
  • [27] Weekly docetaxel and epirubicin in treatment of advanced hormone-refractory prostate cancer
    Petrioli, Roberto
    Paolelli, Loretta
    Francini, Edoardo
    Manganelli, Antonio
    Salvestrini, Francesco
    Francini, Guido
    UROLOGY, 2007, 69 (01) : 142 - 146
  • [28] Hormone-refractory prostate cancer
    Alexandre, I.
    Rixe, O.
    ANNALES D UROLOGIE, 2007, 41 (02) : 47 - 55
  • [29] PACLITAXEL PLUS ESTRAMUSTINE IN METASTATIC HORMONE-REFRACTORY PROSTATE-CANCER
    HUDES, GR
    NATHAN, FE
    KHATER, C
    GREENBERG, R
    GOMELLA, L
    STERN, C
    MCALEER, C
    SEMINARS IN ONCOLOGY, 1995, 22 (05) : 41 - 45
  • [30] Weekly docetaxel and zoledronic acid every 4 weeks in hormone-refractory prostate cancer patients
    Gianfilippo Bertelli
    Abdelhamid Heouaine
    Giuseppe Arena
    Ambrogio Botto
    Ornella Garrone
    Ida Colantonio
    Marcella Occelli
    Elena Fea
    Silvia Giubergia
    Marco Merlano
    Cancer Chemotherapy and Pharmacology, 2006, 57 : 46 - 51
12345